Inventor
Geoffrey T. Yarranton
Inventor
Burlingame, CA, US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes7%
B82YSpecific uses or applications of nanostructures2%
C07HSugars2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
A01KAnimal husbandry1%
C07DHeterocyclic compounds1%
PatentTitleYear
10,919,983Immunoglobulin variable region cassette exchange202110,080,792Influenza vaccine and therapy20189,290,571'Antibodies to EphA3'20169,127,046'Secretion of antibodies without signal peptides from bacteria'20159,109,032'Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow'20159,045,539'Anti-EMR1 antibodies'20159,017,674'Antibodies to granulocyte-macrophage colony-stimulating factor'20158,877,191'Antibodies to the PcrV antigen of Pseudomonas aeruginosa'20148,834,870'Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3'20148,828,393'Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist'20148,664,365'Antibodies to EphA3'20148,642,039'Method of treating a staphylococcus infection in a patient having a low-level pathogenic Pseudomonas aeruginosa infection'20148,637,016'EphA3 antibodies for the treatment of solid tumors'20148,398,972'Methods of treating dementia using a GM-CSF antagonist'20138,211,648'Secretion of antibodies without signal peptides from bacteria'20128,168,183'Antibodies to granulocyte-macrophage colony-stimulating factor'20128,075,885'Methods of treating heart failure using an anti-GM-CSF antibody'20118,044,181'Antibodies to the PcrV antigen of Pseudomonas aeruginosa'20118,034,787'Enzyme-cleavable prodrug compounds'20117,981,843'Antibody specificity transfer using minimal essential binding determinants'20117,939,076'Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist'20117,816,317'Tripeptide prodrug compounds'20107,696,313'Prodrug compounds with isoleucine'20107,425,541'Enzyme-cleavable prodrug compounds'20087,329,507'Prodrug compounds with isoleucine'20087,214,663'Tripeptide prodrug compounds'20077,129,261'Cytotoxic agents'20067,115,573'Prodrug compounds with an isoleucine'20066,653,101'Recombinant DNA method and host cells'20035,965,405'Method for producing Fv fragments in eukaryotic cells'19995,891,693'Recombinant DNA methods vectors and host cells'19995,879,936'Recombinant DNA methods, vectors and host cells'19995,866,359'Transactivation method of regulating foreign gene expression'19995,864,019'Multivalent antigen-binding proteins'19995,747,308'Recombinant DNA method'19985,015,573'DNA vectors and their use in recombinant DNA technology'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–2003Based in Winnersh, GB· patent location history
1998–1999Based in Berkshire, GB· patent location history
1999Based in Reading, GB· patent location history
2006–2011Patents assigned to MEDAREX INC (9)· patent assignee history
2006–2021Based in Burlingame, CA, US· patent location history
2011–2016Patents assigned to KALOBIOS PHARMACEUTICALS INC (16)· patent assignee history
2011–2015Patents assigned to BEBBINGTON CHRISTOPHER R (13)· patent assignee history
2011–2015Patents assigned to YARRANTON GEOFFREY T (13)· patent assignee history
2012–2015Patents assigned to LUEHRSEN KENNETH (5)· patent assignee history
2013–2015Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KALOBIOS PHARMACEUTICALS INC | 16 | 2011–2016 |
| BEBBINGTON CHRISTOPHER R | 13 | 2011–2015 |
| YARRANTON GEOFFREY Tself | 13 | 2011–2015 |
| MEDAREX INC | 9 | 2006–2011 |
| LUEHRSEN KENNETH | 5 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Burlingame, California, US | 23 | 2006–2021 |
| South San Francisco, California, US | 5 | 2013–2015 |
| Winnersh, GB | 3 | 1991–2003 |
| Reading, GB | 2 | 1999 |
| Berkshire, GB | 2 | 1998–1999 |